Healthlead PCL
SET:HL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Healthlead PCL
SET:HL
|
TH |
|
J
|
Jiangsu Changqing Agrochemical Co Ltd
SZSE:002391
|
CN |
|
Naigai Co Ltd
TSE:8013
|
JP |
|
4imprint Group PLC
LSE:FOUR
|
UK |
|
MNC Vision Networks Tbk PT
IDX:IPTV
|
ID |
|
N
|
Novatek PAO
LSE:NVTK
|
RU |
|
C
|
CCL Industries Inc
TSX:CCL.B
|
CA |
|
Allianz SE
XETRA:ALV
|
DE |
|
Heads UP Ventures Limited
NSE:HEADSUP
|
IN |
|
S
|
Shaanxi Huaqin Technology Industry Co Ltd
SSE:688281
|
CN |
|
H
|
Hexagon Purus ASA
OSE:HPUR
|
NO |
|
A
|
AIM Industrial Growth Freehold and Leasehold Real Estate Investment Trust
SET:AIMIRT
|
TH |
|
R
|
Reditus Sociedade Gestora de Participacoes Sociais SA
ELI:RED
|
PT |
|
Bloomsbury Publishing PLC
LSE:BMY
|
UK |
|
Yancoal Australia Ltd
ASX:YAL
|
AU |
|
S
|
Srisawad Capital 1969 PCL
SET:SCAP
|
TH |
|
Trigano SA
PAR:TRI
|
FR |
|
B
|
Betagro PCL
SET:BTG
|
TH |
|
Vidrala SA
OTC:VDRFF
|
ES |
|
Elisa Oyj
OMXH:ELISA
|
FI |
|
I
|
Ichitan Group PCL
SET:ICHI
|
TH |
|
Oberoi Realty Ltd
NSE:OBEROIRLTY
|
IN |
|
Agora Hospitality Group Co Ltd
TSE:9704
|
JP |
Balance Sheet
Balance Sheet Decomposition
Healthlead PCL
Healthlead PCL
Balance Sheet
Healthlead PCL
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
27
|
35
|
705
|
146
|
335
|
169
|
|
| Cash |
0
|
4
|
4
|
705
|
146
|
35
|
36
|
|
| Cash Equivalents |
0
|
23
|
31
|
0
|
0
|
300
|
133
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
507
|
223
|
348
|
|
| Total Receivables |
0
|
21
|
17
|
22
|
24
|
37
|
43
|
|
| Accounts Receivables |
0
|
13
|
2
|
6
|
16
|
21
|
26
|
|
| Other Receivables |
0
|
8
|
14
|
16
|
9
|
16
|
17
|
|
| Inventory |
0
|
139
|
131
|
159
|
210
|
232
|
291
|
|
| Other Current Assets |
0
|
1
|
3
|
2
|
2
|
21
|
4
|
|
| Total Current Assets |
0
|
188
|
186
|
888
|
890
|
848
|
854
|
|
| PP&E Net |
0
|
70
|
193
|
192
|
338
|
452
|
549
|
|
| PP&E Gross |
0
|
70
|
193
|
192
|
338
|
452
|
549
|
|
| Accumulated Depreciation |
0
|
20
|
38
|
36
|
46
|
70
|
105
|
|
| Intangible Assets |
0
|
7
|
7
|
9
|
8
|
8
|
10
|
|
| Goodwill |
0
|
0
|
16
|
16
|
16
|
16
|
16
|
|
| Note Receivable |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
80
|
0
|
0
|
0
|
16
|
30
|
35
|
|
| Other Long-Term Assets |
0
|
31
|
12
|
15
|
21
|
29
|
36
|
|
| Other Assets |
0
|
0
|
16
|
16
|
16
|
16
|
16
|
|
| Total Assets |
80
N/A
|
297
+271%
|
414
+40%
|
1 118
+170%
|
1 288
+15%
|
1 382
+7%
|
1 499
+8%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
108
|
94
|
107
|
132
|
136
|
137
|
|
| Accrued Liabilities |
0
|
12
|
18
|
8
|
13
|
12
|
17
|
|
| Short-Term Debt |
0
|
27
|
24
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
13
|
17
|
16
|
20
|
25
|
36
|
|
| Other Current Liabilities |
0
|
8
|
14
|
13
|
23
|
25
|
21
|
|
| Total Current Liabilities |
0
|
168
|
167
|
144
|
187
|
199
|
211
|
|
| Long-Term Debt |
0
|
16
|
101
|
102
|
148
|
199
|
260
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
4
|
5
|
6
|
11
|
16
|
22
|
|
| Total Liabilities |
0
N/A
|
189
+91 186%
|
273
+45%
|
252
-8%
|
346
+37%
|
414
+20%
|
493
+19%
|
|
| Equity | ||||||||
| Common Stock |
80
|
80
|
100
|
136
|
136
|
136
|
136
|
|
| Retained Earnings |
0
|
22
|
41
|
82
|
158
|
184
|
222
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
648
|
648
|
648
|
648
|
|
| Other Equity |
0
|
7
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
80
N/A
|
108
+35%
|
141
+30%
|
866
+516%
|
942
+9%
|
968
+3%
|
1 006
+4%
|
|
| Total Liabilities & Equity |
80
N/A
|
297
+271%
|
414
+40%
|
1 118
+170%
|
1 288
+15%
|
1 382
+7%
|
1 499
+8%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
272
|
272
|
272
|
272
|
272
|
272
|
272
|
|